#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

CD39/Adenosine Pathway Is Involved in AIDS Progression


HIV-1 infection is characterized by a chronic activation of the immune system and suppressed function of T lymphocytes. Regulatory CD4+ CD25high FoxP3+CD127low T cells (Treg) play a key role in both conditions. Here, we show that HIV-1 positive patients have a significant increase of Treg-associated expression of CD39/ENTPD1, an ectoenzyme which in concert with CD73 generates adenosine. We show in vitro that the CD39/adenosine axis is involved in Treg suppression in HIV infection. Treg inhibitory effects are relieved by CD39 down modulation and are reproduced by an adenosine-agonist in accordance with a higher expression of the adenosine A2A receptor on patients' T cells. Notably, the expansion of the Treg CD39+ correlates with the level of immune activation and lower CD4+ counts in HIV-1 infected patients. Finally, in a genetic association study performed in three different cohorts, we identified a CD39 gene polymorphism that was associated with down-modulated CD39 expression and a slower progression to AIDS.


Vyšlo v časopise: CD39/Adenosine Pathway Is Involved in AIDS Progression. PLoS Pathog 7(7): e32767. doi:10.1371/journal.ppat.1002110
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1002110

Souhrn

HIV-1 infection is characterized by a chronic activation of the immune system and suppressed function of T lymphocytes. Regulatory CD4+ CD25high FoxP3+CD127low T cells (Treg) play a key role in both conditions. Here, we show that HIV-1 positive patients have a significant increase of Treg-associated expression of CD39/ENTPD1, an ectoenzyme which in concert with CD73 generates adenosine. We show in vitro that the CD39/adenosine axis is involved in Treg suppression in HIV infection. Treg inhibitory effects are relieved by CD39 down modulation and are reproduced by an adenosine-agonist in accordance with a higher expression of the adenosine A2A receptor on patients' T cells. Notably, the expansion of the Treg CD39+ correlates with the level of immune activation and lower CD4+ counts in HIV-1 infected patients. Finally, in a genetic association study performed in three different cohorts, we identified a CD39 gene polymorphism that was associated with down-modulated CD39 expression and a slower progression to AIDS.


Zdroje

1. AppayVNixonDFDonahoeSMGillespieGMDongT 2000 HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med 192 63 75

2. AandahlEMMichaelssonJMorettoWJHechtFMNixonDF 2004 Human CD4+CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J Virol 78 2454 2459

3. CabreraRTuZXuYFirpiRJRosenHR 2004 An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection. Hepatology 40 1062 1071

4. KinterALHennesseyMBellAKernSLinY 2004 CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J Exp Med 200 331 343

5. KaredHLelievreJDDonkova-PetriniVAoubaAMelicaG 2008 HIV-specific regulatory T cells are associated with higher CD4 cell counts in primary infection. AIDS 22 2451 2460

6. WeissLDonkova-PetriniVCaccavelliLBalboMCarbonneilC 2004 Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood 104 3249 3256

7. CollisonLWWorkmanCJKuoTTBoydKWangY 2007 The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450 566 569

8. PaustSLuLMcCartyNCantorH 2004 Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease. Proc Natl Acad Sci U S A 101 10398 10403

9. VignaliDACollisonLWWorkmanCJ 2008 How regulatory T cells work. Nat Rev Immunol 8 523 532

10. BorsellinoGKleinewietfeldMDi MitriDSternjakADiamantiniA 2007 Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 110 1225 1232

11. DeaglioSDwyerKMGaoWFriedmanDUshevaA 2007 Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 204 1257 1265

12. MandapathilMSzczepanskiMJSzajnikMRenJLenznerDE 2009 Increased ectonucleotidase expression and activity in regulatory T cells of patients with head and neck cancer. Clin Cancer Res 15 6348 6357

13. AirasLHellmanJSalmiMBonoPPuurunenT 1995 CD73 is involved in lymphocyte binding to the endothelium: characterization of lymphocyte-vascular adhesion protein 2 identifies it as CD73. J Exp Med 182 1603 1608

14. BoursMJSwennenELDi VirgilioFCronsteinBNDagneliePC 2006 Adenosine 5′-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol Ther 112 358 404

15. RobsonSCSevignyJZimmermannH 2006 The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance. Purinergic Signal 2 409 430

16. SitkovskyMVLukashevDApasovSKojimaHKoshibaM 2004 Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. Annu Rev Immunol 22 657 682

17. ThielMCaldwellCCSitkovskyMV 2003 The critical role of adenosine A2A receptors in downregulation of inflammation and immunity in the pathogenesis of infectious diseases. Microbes Infect 5 515 526

18. HuangSApasovSKoshibaMSitkovskyM 1997 Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion. Blood 90 1600 1610

19. MaliszewskiCRDelespesseGJSchoenbornMAArmitageRJFanslowWC 1994 The CD39 lymphoid cell activation antigen. Molecular cloning and structural characterization. J Immunol 153 3574 3583

20. HendelHCaillat-ZucmanSLebuanecHCarringtonMO'BrienS 1999 New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS. J Immunol 162 6942 6946

21. FriedmanDJKunzliBMYIARSevignyJBerberatPO 2009 From the Cover: CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease. Proc Natl Acad Sci U S A 106 16788 16793

22. Le ClercSLimouSCoulongesCCarpentierWDinaC 2009 Genomewide association study of a rapid progression cohort identifies new susceptibility alleles for AIDS (ANRS Genomewide Association Study 03). J Infect Dis 200 1194 1201

23. LimouSLe ClercSCoulongesCCarpentierWDinaC 2009 Genomewide association study of an AIDS-nonprogression cohort emphasizes the role played by HLA genes (ANRS Genomewide Association Study 02). J Infect Dis 199 419 426

24. GeDZhangKNeedACMartinOFellayJ 2008 WGAViewer: software for genomic annotation of whole genome association studies. Genome Res 18 640 643

25. DixonALLiangLMoffattMFChenWHeathS 2007 A genome-wide association study of global gene expression. Nat Genet 39 1202 1207

26. DwyerKMDeaglioSGaoWFriedmanDStromTB 2007 CD39 and control of cellular immune responses. Purinergic Signal 3 171 180

27. MandapathilMLangSGorelikEWhitesideTL 2009 Isolation of functional human regulatory T cells (Treg) from the peripheral blood based on the CD39 expression. J Immunol Methods 346 55 63

28. LealDBStreherCABertoncheli CdeMCarliLFLealCA 2005 HIV infection is associated with increased NTPDase activity that correlates with CD39-positive lymphocytes. Biochim Biophys Acta 1746 129 134

29. Schulze Zur WieschJThomssenAHartjenPTothILehmannC 2011 Comprehensive Analysis of Frequency and Phenotype of T Regulatory Cells in HIV Infection: CD39 expression of FoxP3+ T regulatory cells correlates with progressive disease. J Virol 85 1287 1297

30. NigamPVeluVKannanganatSChennareddiLKwaS 2010 Expansion of FOXP3+ CD8 T cells with suppressive potential in colorectal mucosa following a pathogenic Simian Immunodeficiency Virus infection correlates with diminished antiviral T cell response and viral control. J Immunol 184 1690 1701

31. BurnstockG 2006 Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol Rev 58 58 86

32. MartinCLeoneMViviandXAyemMLGuieuR 2000 High adenosine plasma concentration as a prognostic index for outcome in patients with septic shock. Crit Care Med 28 3198 3202

33. OguraYSutterwalaFSFlavellRA 2006 The inflammasome: first line of the immune response to cell stress. Cell 126 659 662

34. ErdmannAAGaoZGJungUFoleyJBorensteinT 2005 Activation of Th1 and Tc1 cell adenosine A2A receptors directly inhibits IL-2 secretion in vitro and IL-2-driven expansion in vivo. Blood 105 4707 4714

35. OhtaASitkovskyM 2001 Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414 916 920

36. OhtaAOhtaAMadasuMKiniRSubramanianM 2009 A2A adenosine receptor may allow expansion of T cells lacking effector functions in extracellular adenosine-rich microenvironments. J Immunol 183 5487 5493

37. ZarekPEHuangCTLutzERKowalskiJHortonMR 2008 A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells. Blood 111 251 259

38. KobieJJShahPRYangLRebhahnJAFowellDJ 2006 T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5′-adenosine monophosphate to adenosine. J Immunol 177 6780 6786

39. AswadFKawamuraHDennertG 2005 High sensitivity of CD4+CD25+ regulatory T cells to extracellular metabolites nicotinamide adenine dinucleotide and ATP: a role for P2X7 receptors. J Immunol 175 3075 3083

40. DongRPKameokaJHegenMTanakaTXuY 1996 Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response. J Immunol 156 1349 1355

41. SitkovskyMVOhtaA 2005 The ‘danger’ sensors that STOP the immune response: the A2 adenosine receptors? Trends Immunol 26 299 304

42. GajewskiTFMengYHarlinH 2006 Immune suppression in the tumor microenvironment. J Immunother 29 233 240

43. KinterAMcNallyJRigginLJacksonRRobyG 2007 Suppression of HIV-specific T cell activity by lymph node CD25+ regulatory T cells from HIV-infected individuals. Proc Natl Acad Sci U S A 104 3390 3395

44. EstesJDLiQReynoldsMRWietgrefeSDuanL 2006 Premature induction of an immunosuppressive regulatory T cell response during acute simian immunodeficiency virus infection. J Infect Dis 193 703 712

45. LichterfeldMKaufmannDEYuXGMuiSKAddoMM 2004 Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells. J Exp Med 200 701 712

46. NikolovaMLelievreJDCarriereMBensussanALevyY 2009 Regulatory T cells differentially modulate the maturation and apoptosis of human CD8+ T-cell subsets. Blood 113 4556 4565

47. GouttefangeasCMansurIBensussanABoumsellL 1995 Biochemical analysis and epitope mapping of mAb defining CD39. SchlossmanSFBoumsellLGilksWHarlanJMKishimotoT Leucocyte Typing V New York Oxford University Press 383 385

48. WinklerCAHendelHCarringtonMSmithMWNelsonGW 2004 Dominant effects of CCR2–CCR5 haplotypes in HIV-1 disease progression. J Acquir Immune Defic Syndr 37 1534 1538

49. BalkauB 1996 [An epidemiologic survey from a network of French Health Examination Centres, (D.E.S.I.R.): epidemiologic data on the insulin resistance syndrome]. Rev Epidemiol Sante Publique 44 373 375

50. van ManenDKootstraNABoeser-NunninkBHandulleMAvan't WoutAB 2009 Association of HLA-C and HCP5 gene regions with the clinical course of HIV-1 infection. AIDS 23 19 28

51. HerbeckJTGottliebGSWinklerCANelsonGWAnP 2010 Multistage genomewide association study identifies a locus at 1q41 associated with rate of HIV-1 disease progression to clinical AIDS. J Infect Dis 201 618 626

52. PriceALPattersonNJPlengeRMWeinblattMEShadickNA 2006 Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38 904 909

53. MarchiniJHowieBMyersSMcVeanGDonnellyP 2007 A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet 39 906 913

54. FisherRAImmerFRTedinO 1932 The Genetical Interpretation of Statistics of the Third Degree in the Study of Quantitative Inheritance. Genetics 17 107 124

Štítky
Hygiena a epidemiológia Infekčné lekárstvo Laboratórium

Článok vyšiel v časopise

PLOS Pathogens


2011 Číslo 7
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#